Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.

Sullivan, S D; Jensen, D M; Bernstein, D E; Hassanein, T I; Foster, G R; Lee, S S; Cheinquer, H; Craxi, A; Cooksley, Graham; Klaskala, W; Pettit, K; Patel, K K; Green, J

Sullivan, S D; Jensen, D M; Bernstein, D E; Hassanein, T I; Foster, G R; Lee, S S; Cheinquer, H; Craxi, A; Cooksley, Graham; Klaskala, W; Pettit, K; Patel, K K; Green, J.

Affiliation

Sullivan SD; University of Washington, Seattle WA 98195, USA.

Am J Gastroenterol ; 99(8): 1490-6, 2004 Aug.

Article in En | MEDLINE | ID: mdl-15307866

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Interferon-alpha / Hepatitis C, Chronic Type of study: Clinical_trials / Health_economic_evaluation / Risk_factors_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Gastroenterol Year: 2004 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links